TAMOXIFEN ELEVATES TRANSFORMING GROWTH-FACTOR-BETA AND SUPPRESSES DIET-INDUCED FORMATION OF LIPID LESIONS IN MOUSE AORTA

被引:124
作者
GRAINGER, DJ
WITCHELL, CM
METCALFE, JC
机构
[1] Department of Biochemistry, University of Cambridge, Cambridge, CB2 1QW, Tennis Court Road
关键词
D O I
10.1038/nm1095-1067
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
When C57B16 male mice are fed a high-fat diet, they develop significant fatty streak lesions in the aorta. Addition of tamoxifen (TMX) to a high-fat diet, equivalent to a dose of approximately 1 mg TMX per kg body weight per day, suppressed the diet-induced increase in the area of lipid staining in the aortic sinus of the mice by 88% and in the average number of lesions by 86%. The TMX-treated mice had 11% +/- 5% less total plasma cholesterol, with most of the reduction in the high density lipoprotein fraction, whereas plasma triglycerides were significantly elevated, and circulating concentrations of 17 beta-estradiol and testosterone were unaffected. Both circulating and aortic concentrations of active and latent transforming growth factor-beta (TGF-beta) were substantially elevated by TMX. The inhibition of lesion formation may be due, at least in part, to cardiovascular protection by TGF-beta.
引用
收藏
页码:1067 / 1073
页数:7
相关论文
共 40 条
[1]  
ALLAIN CC, 1974, CLIN CHEM, V20, P470
[2]   ADJUVANT TAMOXIFEN IN PRIMARY BREAST-CANCER - INFLUENCE ON PLASMA-LIPIDS AND ANTITHROMBIN-III LEVELS [J].
BERTELLI, G ;
PRONZATO, P ;
AMOROSO, D ;
CUSIMANO, MP ;
CONTE, PF ;
MONTAGNA, G ;
BERTOLINI, S ;
ROSSO, R .
BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (03) :307-310
[3]  
BUTTA A, 1992, CANCER RES, V52, P4261
[4]   EFFECT OF TAMOXIFEN ON ESTROGEN BINDING, LIPID AND LIPOPROTEIN CONCENTRATIONS AND BLOOD-CLOTTING PARAMETERS IN PREMENOPAUSAL WOMEN WITH BREAST PAIN [J].
CALEFFI, M ;
FENTIMAN, IS ;
CLARK, GM ;
WANG, DY ;
NEEDHAM, J ;
CLARK, K ;
LAVILLE, A ;
LEWIS, B .
JOURNAL OF ENDOCRINOLOGY, 1988, 119 (02) :335-339
[5]   THE GROWTH-INHIBITION OF HUMAN BREAST-CANCER CELLS BY A NOVEL SYNTHETIC PROGESTIN INVOLVES THE INDUCTION OF TRANSFORMING GROWTH-FACTOR-BETA [J].
COLLETTA, AA ;
WAKEFIELD, LM ;
HOWELL, FV ;
DANIELPOUR, D ;
BAUM, M ;
SPORN, MB .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (01) :277-283
[6]   ANTIESTROGENS INDUCE THE SECRETION OF ACTIVE TRANSFORMING GROWTH-FACTOR-BETA FROM HUMAN FETAL FIBROBLASTS [J].
COLLETTA, AA ;
WAKEFIELD, LM ;
HOWELL, FV ;
VANROOZENDAAL, KEP ;
DANIELPOUR, D ;
EBBS, SR ;
SPORN, MB ;
BAUM, M .
BRITISH JOURNAL OF CANCER, 1990, 62 (03) :405-409
[7]  
EMESON EE, 1993, AM J PATHOL, V142, P1906
[8]   THE PHARMACOLOGY AND CLINICAL USES OF TAMOXIFEN [J].
FURR, BJA ;
JORDAN, VC .
PHARMACOLOGY & THERAPEUTICS, 1984, 25 (02) :127-205
[9]   MOLECULAR-CLONING AND CHARACTERIZATION OF 2B7, A RAT MESSENGER-RNA WHICH DISTINGUISHES SMOOTH-MUSCLE CELL PHENOTYPES INVITRO AND IS IDENTICAL TO OSTEOPONTIN (SECRETED PHOSPHOPROTEIN-I, 2AR) [J].
GIACHELLI, C ;
BAE, N ;
LOMBARDI, D ;
MAJESKY, M ;
SCHWARTZ, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 177 (02) :867-873
[10]   OSTEOPONTIN IS ELEVATED DURING NEOINTIMA FORMATION IN RAT ARTERIES AND IS A NOVEL COMPONENT OF HUMAN ATHEROSCLEROTIC PLAQUES [J].
GIACHELLI, CM ;
BAE, N ;
ALMEIDA, M ;
DENHARDT, DT ;
ALPERS, CE ;
SCHWARTZ, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) :1686-1696